Kuvatris Therapeutics, Inc.
PXMDDelisted Aug 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811623
Kuvatris Therapeutics, Inc. was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Mar 14, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Holders of 5% or more of PXMD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kuvatris Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lind Global Fund II LP | 13G/A | 9.90%985.0K shares | – | Nov 29, 20234 filings | Feb 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Kuvatris Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 20255:10 PM ET | Lind Global Fund II LPand 2 others | 13G/A | 9.90%985.0K shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Lind Global Fund II LP | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Lind Global Fund II LP | 13G/AOld format | – | – | – | SEC |
| Nov 29, 2023 | Lind Global Fund II LP | 13GOld format | – | New | – | SEC |
| Sep 9, 2022 | TardiMed Sciences LLC | 13DOld format | – | New | – | SEC |
| Sep 9, 2022 | Blue Cane Partners, LLC | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
4 notices from officers, directors and other affiliates planning to sell Kuvatris Therapeutics, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Aug 30, 20234:26 PM ET | Weisman Howard J.Officer · Chief Executive Officer | 44.1K | $20.6K | Aug 28, 2023 | Georgeson Securities Corp | SEC |
| Aug 30, 20234:19 PM ET | Rome ZacharyOfficer · Chief Operating Officer | 25.6K | $12.4K | Aug 28, 2023 | Georgeson Securities Corp | SEC |
| Aug 30, 20234:02 PM ET | Derby MichaelOfficer · Executive Chairman | 13.5K | $6.62K | Aug 28, 2023 | Georgeson Securities Corp | SEC |
| Aug 21, 20233:48 PM ET | Rome ZacharyOfficer · Chief Operating Officer | 50.0K | $29.0K | Aug 21, 202310b5-1 | Georgeson Securities Corp | SEC |